head_banner

News

Breaking Through World-class Industry Challenges|”ENDOANGEL” Contributing The “China solution” To World Medicine

ENDOANGEL

(Hu Shan, General Manager of Wuhan ENDOANGEL Medical Technology Co.,Ltd., demonstrated the application scenario of "ENDOANGEL")

When it comes to artificial intelligence (AI), people will definitely think of technologies such as autonomous driving and facial recognition that will completely change the future of human science and technology. Their emergence greatly extends the scope of human capabilities and breaks through the physiological limits of humans. But do you know "ENDORANGEL"? The "ENDOANGEL", known as the third eye of endoscopists, is precisely the leader in the application of AI in the field of digestive endoscopy.

"ENDOANGEL" EndoAngel® is a globally pioneering artificial intelligence digestive endoscopy quality control and auxiliary diagnosis system based on deep learning technology. It is a fully functional AI product that can effectively monitor blind spots in gastrointestinal imaging, provide real-time assistance to prompt suspicious lesions, improve the quality of endoscopic examination,and enhance the detection rate of gastrointestinal cancer lesions. Multiple studies led by Renmin Hospital of Wuhan University and published in top international journals such as LancetGastroenterol Hepatol, Endoscopy, and GastrointestEndosc have shown that "ENDOANGEL" can greatly improve the accuracy of early cancer and precancerous lesion recognition.

Nowadays, "ENDOANGEL" have begun to show off their skills. Local patients can obtain objective and accurate endoscopic examination reports without having to travel to provincial hospitals or wait for the specialists.

Mr. Jin, 67 years old from Yichang City, Hubei Province, China, is the beneficiary of this achievement. In February 2022, Mr. Jin went to The First People's Hospital of Yichang, Hubei Province for a gastroscopy examination. When the gastric antrum is found, the "ENDOANGEL"displays a red box and prompts "high-risk, please observe carefully". The doctor took a biopsy according to the prompt and performed endoscopic submucosal dissection surgery on the digestive tract. The pathological results showed "highly differentiated adenocarcinoma in the gastric antrum mucosa". After 3 months of treatment, in May 2023, Mr. Jin went to the hospital for a follow-up sampling and the conclusion was "mild chronic atrophic gastritis".

The discovery of early cancer and timely surgery allowed Mr. Jin to luckily avoid the death. And Yaowei Ai, the director of the Department of Gastroenterology at The First People's Hospital of Yichang, who performed the surgery on Mr. Jin, was even more excited: "I am particularly proud to be able to use the medical equipment invented by the Chinese to save the lives of patients!"

As of now, it has applied for 179 invention patents and 100 have been authorized; Approved 6 Class II medical device registration certificates, 1 Class III innovative medical device registration certificate, and 4 European CE certifications; The "Innovative Medical Device Class III Registration Certificate" it obtained is the first artificial intelligence assisted diagnosis Class III certificate in Hubei, China, and the second approved innovative medical device Class III certificate in Hubei, China.

In order to enable more grassroots hospitals to master the application technology of "ENDOANGEL", since June 2020, the "ENDOANGEL" R&D team has simultaneously launched 9 sessions of "ENDOANGEL" learning courses online and offline, cultivating a total of 332 endoscopists. As of October 2023, "ENDOANGEL" has been applied in more than 600 hospitals in Beijing, Shanghai, Guangdong, Hubei, Hunan, Henan and other provinces and cities, assisting physicians in discovering 24816 cases of early gastrointestinal cancer and precancerous lesions.

This invention with the characteristic of "global innovation" has also been given academic lectures or surgical demonstrations at international conferences in Long Island, Italy, Cairo, Egypt, Seoul, South Korea, and other places. "ENDOANGEL" has currently entered clinical trials in countries such as Singapore and Italy, contributing the "Chinese solution" to global medicine.

The successful development of "ENDOANGEL" not only provides reliable technical support for clinical doctors, but also provides important support for promoting graded diagnosis and treatment, and promoting the equalization of public health medical resources. The successful development of "ENDOANGEL" is a brilliant display of "Chinese wisdom" in the field of medical science worldwide.


Post time: Apr-08-2024